PCSK9 and chronic kidney disease: Beyond its well-established role in lipid homeostasis, PCSK9 is increasingly recognized as a pleiotropic molecule involved in vascular inflammation, endothelial dysfunction, and renal disease progression, making it a promising biomarker and therapeutic target in CKD and its cardiovascular complications [140,141,142,143].